Comments
Loading...

Benitec Biopharma

BNTCNASDAQ
Logo brought to you by Benzinga Data
$8.56
0.22.39%
Last update: 9:07 AM
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$30.00
Lowest Price Target1
$4.00
Consensus Price Target1
$16.00

Benitec Biopharma (NASDAQ:BNTC) Stock, Analyst Ratings, Price Targets, Forecasts

Benitec Biopharma Inc has a consensus price target of $16 based on the ratings of 5 analysts. The high is $30 issued by Piper Sandler on June 13, 2024. The low is $4 issued by HC Wainwright & Co. on September 23, 2022. The 3 most-recent analyst ratings were released by Guggenheim, Leerink Partners, and Piper Sandler on September 12, 2024, July 22, 2024, and June 13, 2024, respectively. With an average price target of $20 between Guggenheim, Leerink Partners, and Piper Sandler, there's an implied 132.29% upside for Benitec Biopharma Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
1
Jun
1
Jul
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Guggenheim
Leerink Partners
Piper Sandler
JMP Securities
HC Wainwright & Co.

1calculated from analyst ratings

Analyst Ratings for Benitec Biopharma

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Benitec Biopharma (BNTC) stock?

A

The latest price target for Benitec Biopharma (NASDAQ:BNTC) was reported by Guggenheim on September 12, 2024. The analyst firm set a price target for $17.00 expecting BNTC to rise to within 12 months (a possible 98.60% upside). 7 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Benitec Biopharma (BNTC)?

A

The latest analyst rating for Benitec Biopharma (NASDAQ:BNTC) was provided by Guggenheim, and Benitec Biopharma initiated their buy rating.

Q

When was the last upgrade for Benitec Biopharma (BNTC)?

A

There is no last upgrade for Benitec Biopharma

Q

When was the last downgrade for Benitec Biopharma (BNTC)?

A

There is no last downgrade for Benitec Biopharma.

Q

When is the next analyst rating going to be posted or updated for Benitec Biopharma (BNTC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Benitec Biopharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Benitec Biopharma was filed on September 12, 2024 so you should expect the next rating to be made available sometime around September 12, 2025.

Q

Is the Analyst Rating Benitec Biopharma (BNTC) correct?

A

While ratings are subjective and will change, the latest Benitec Biopharma (BNTC) rating was a initiated with a price target of $0.00 to $17.00. The current price Benitec Biopharma (BNTC) is trading at is $8.56, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch